Skip to Content
Merck
  • DU-6859a, a new fluoroquinolone agent. Comparative in vitro activity against enteric pathogens and multiresistant outpatient Escherichia coli.

DU-6859a, a new fluoroquinolone agent. Comparative in vitro activity against enteric pathogens and multiresistant outpatient Escherichia coli.

Diagnostic microbiology and infectious disease (1994-09-01)
J F Tomayko, V Korten, B E Murray
ABSTRACT

The activity of DU-6859a, a new fluoroquinolone antimicrobial agent, was compared with that of ciprofloxacin by agar dilution susceptibility testing against enteric pathogens and multiresistant Escherichia coli. The results indicate that DU-6859a inhibits most of these organisms at concentrations similar to those of ciprofloxacin. DU-6859a showed increased activity compared to ciprofloxacin against Campylobacter species isolates.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sitafloxacin sesquihydrate, ≥98% (HPLC)